Mr. Brian Ostrander has served as Vice President of Clinical Operations since 2020 and oversees all aspects of OncoNano’s clinical trial operations and execution. Brian has more than 20 years of experience working in clinical development and operations at pharmaceutical, biotechnology and surgical device companies. Prior to joining OncoNano, he served as Regional Director of Clinical Affairs for Insightec where he led multiple clinical programs. Previously, Brian held various positions of increasing responsibility at Reata Pharmaceuticals in clinical operations and clinical pharmacology. Brian holds a bachelor’s degree in biology from Texas A&M University and a master’s degree in immunology from University of the Incarnate Word.